Features
Prostate cancer screening is important in the early detection of prostate cancer because many patients do not have symptoms. This guide reviews current screening tests, recommendations, and risk factors.
Features
This information can help clinicians and patients understand the risks and benefits of prostate cancer screening. Provider and patient sheets are included.
Drug News
Male baldness is associated with prostate cancer, with more severe balding patterns more strongly associated with cancer.
Drug News
The protein SPOP, which is most frequently mutated in human prostate cancers, is a key regulator of androgen receptor activity that prevents uncontrolled growth of cells in the prostate and thus helps prevent cancer.
Drug News
In men with an initial benign biopsy or transurethral resection of the prostate, obesity is associated with the presence of precancerous lesions in the initial biopsy and a higher risk of developing prostate cancer.
Drug News
Circumcision appears to confer a protective effect against the development of prostate cancer.
Drug News
For men with non-metastatic prostate cancer, the risks of lethal prostate cancer and all-cause mortality are significantly reduced with replacement of carbohydrates by vegetable fats.
Drug News
Copy number variants (CNVs) of two loci are linked to a significantly higher risk of prostate cancer.
Drug News
A genetic score can modestly improve the prediction of which men are likely to have positive biopsies for prostate cancer after an initial negative biopsy.
Drug News
Copy number variation (CNV) in both malignant and benign prostate tissue is predictive of prostate cancer relapse.
